Elixirr International Plc (ELIX) AI Stock Analysis

• Market Cap: £345.97M
• Dividend Yield: 2.13%
• Average Volume (3M): 101.98K
• Price to Earnings (P/E): 7.3
• Beta (1Y): 1.09
• Revenue Growth: 32.67%
• EPS Growth: -1.61%
• Country: UK
• Employees: 565
• Sector: Industrials
• Sector Strength: 72
• Industry: Consulting Services
• EPS (TTM): 0.29
• Shares Outstanding: 50,031,155
• 10 Day Avg. Volume: 75,512
• 30 Day Avg. Volume: 101,977
• PEG Ratio: -2.62
• Price to Book (P/B): 2.57
• Price to Sales (P/S): 3.04
• P/FCF Ratio: 11.78
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.59
• Revenue Forecast (FY): £170.69M

• Rating: 75 Outperform
• Price Target: 959.00p ▲(14.17% Upside)
• Action: Upgraded Date: 12/07/25
• Date: Action: Upgraded 12/07/25

Elixirr International Plc's overall stock score is driven by its strong financial performance and positive corporate events, which highlight its growth trajectory and strategic positioning. However, bearish technical indicators suggest caution in the short term. The valuation is fair, supporting a balanced investment outlook.

Positive Factors

Strong revenue growth

Sustained >30% revenue growth indicates durable demand for Elixirr’s consulting services and successful client acquisition. Over 2–6 months this supports scale advantages, stronger client references, and reinvestment capacity to expand capabilities and win larger, higher‑margin engagements.

High margins and operational efficiency

Consistent gross and net margins plus healthy EBIT/EBITDA margins reflect efficient project delivery and pricing power. Margin durability supports reinvestment in talent and technology, enabling competitive differentiation and resilience through project cycles over the medium term.

Strong balance sheet and cash generation

Low leverage and substantial free cash flow growth provide financial flexibility for strategic hires, selective M&A, and cyclical cushioning. This liquidity and conservative capital structure underpin long‑term stability and the ability to fund growth without overreliance on external financing.

Negative Factors

Declining EPS

Negative EPS growth despite strong revenue expansion suggests margin pressure from investments, mix shifts, or dilution. Persisting EPS contraction can reduce per‑share returns and limit capacity to increase dividends or buybacks until profitability per share recovers.

Project‑based revenue variability

A primarily project‑fee business creates inherent revenue cyclicality and client timing risk. Even with long‑term partnerships, project cadence and client budgets can fluctuate, creating variability in utilization and cash flow that can challenge stable margin and headcount planning.

Limited earnings guidance/transparency

Absence of formal guidance and no earnings call highlights reduces forward visibility for investors. Limited public directional information can hamper market confidence and makes it harder to assess near‑term execution risks or validate management’s strategic progress over the coming quarters.

Elixirr International Plc Business Overview & Revenue Model

Company Description

Elixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. It offers creative, marketing, and self-funded transformation services. The company offers its services for various industries, such as automotive and transportation, manufacturing, business and financial services, charities, energy, utilities and resources, healthcare and pharmaceuticals, insurance, luxury and fashion, travel and leisure, telecommunications, technology, retail and consumer goods, private equity, media, and entertainment and sports industries. Elixirr International plc was founded in 2009 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Elixirr generates revenue primarily through its consulting services, charging clients for project-based work and ongoing advisory services. The company's revenue model is based on fees for consultancy projects, which can vary in complexity and duration. Key revenue streams include management consulting, digital strategy, and operational efficiency projects. Elixirr also benefits from long-term partnerships with various organizations, which can lead to recurring revenue through extended contracts and follow-on work. Additionally, the firm may engage in performance-based contracts where fees are tied to the successful implementation of strategies that drive client growth and efficiency.

Elixirr International Plc Financial Statement Overview

Summary

Elixirr International Plc demonstrates strong financial performance with robust revenue growth, efficient operations, and solid profitability. The company maintains a healthy balance sheet with low leverage and high equity, indicating financial stability and flexibility.

Income Statement

Elixirr International Plc has demonstrated robust growth in revenue with a year-over-year increase from 2023 to 2024. The company maintains strong profitability, evidenced by a healthy gross profit margin and net profit margin. The EBIT and EBITDA margins indicate efficient operational management. Overall, the income statement reflects a solid and growing company with strong financial performance.

Balance Sheet

The company's balance sheet is strong, with a low debt-to-equity ratio, reflecting prudent financial management. The equity ratio is high, indicating a stable capital structure with significant stockholders' equity relative to total assets. Return on equity remains attractive, showcasing the company's ability to generate returns for shareholders. The company's financial stability is underscored by its solid asset base and manageable liabilities.

Cash Flow

Elixirr International Plc exhibits impressive cash flow management, highlighted by substantial free cash flow growth. The operating cash flow to net income ratio is strong, indicating efficient conversion of income into cash. Free cash flow to net income is well-aligned, signaling effective reinvestment and financial strategy. The cash flow statements reflect a healthy liquidity position and sound financial practices.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	129.72M	111.34M	85.89M	71.75M	50.61M	30.32M
Gross Profit	41.91M	35.81M	29.26M	23.16M	17.70M	11.19M
EBITDA	31.87M	27.96M	25.78M	20.02M	14.46M	8.97M
Net Income	18.56M	16.38M	17.24M	12.87M	10.14M	4.79M
Balance Sheet
Total Assets	170.17M	175.89M	154.40M	128.66M	107.17M	87.00M
Cash, Cash Equivalents and Short-Term Investments	2.84M	7.53M	18.13M	20.43M	31.80M	17.50M
Total Debt	14.15M	4.90M	5.36M	5.14M	5.25M	5.29M
Total Liabilities	50.06M	43.78M	34.84M	32.74M	21.13M	16.31M
Stockholders Equity	120.12M	132.11M	119.56M	95.92M	86.04M	70.69M
Cash Flow
Free Cash Flow	29.78M	28.76M	16.67M	15.40M	14.23M	12.12M
Operating Cash Flow	29.86M	28.84M	16.79M	15.73M	14.33M	12.15M
Investing Cash Flow	-26.08M	-21.11M	-14.82M	-18.53M	-3.24M	-1.46M
Financing Cash Flow	-23.26M	-18.58M	-4.06M	-8.85M	3.11M	3.88M

Elixirr International Plc Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 840.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Neutral. The current price of 840 is above the 20-day moving average (MA) of 699.60, above the 50-day MA of 769.74, and above the 200-day MA of 764.48, indicating a neutral trend. The MACD of -19.27 indicates Negative momentum. The RSI at 49.74 is Neutral, neither overbought nor oversold. The STOCH value of 82.21 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:ELIX.

Elixirr International Plc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SRP	79 Outperform	£3.03B	5.87	5.21%	1.27%	0.84%	-62.73%
ELIX	75 Outperform	£345.97M	7.28	15.29%	2.13%	32.67%	-1.61%
YOU	75 Outperform	£229.37M	27.22	7.16%	3.68%	15.99%	―
CPI	64 Neutral	£434.04M	-12.59	9.00%	―	-4.87%	―
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
GTLY	56 Neutral	£102.95M	7.60	5.86%	8.80%	6.04%	-24.55%
DATA	56 Neutral	£554.88M	24.99	3.76%	1.19%	9.25%	-51.82%

Elixirr International Plc Corporate Events

Elixirr Discloses Share Sale by Co-Founder’s Family Member, Ferguson Retains 4.5% Stake

Elixirr International plc has disclosed that Amanda Ferguson, the wife of co-founder and board adviser Ian Ferguson, sold 2,998 ordinary shares in the company on 8 January 2026 at 834p per share. Following the transaction, Ian Ferguson remains beneficially interested in 2,237,385 shares, representing about 4.51% of Elixirr’s issued share capital, indicating that despite the family’s partial disposal, his stake and alignment with shareholders remain significant.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £866.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.